Market Cap (In USD)
132.69 Million
Revenue (In USD)
6.44 Million
Net Income (In USD)
-25.2 Million
Avg. Volume
-
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.0E-6-0.005
- PE
- -
- EPS
- -
- Beta Value
- 52.408
- ISIN
- CA94946J1084
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Ms. Najla Guthrie
- Employee Count
- -
- Website
- https://www.ketamine.one
- Ipo Date
- 2021-10-22
- Details
- KetamineOne Capital Limited, a next generation wellness company, focuses on ketamine assisted therapy and psychedelic medicines through operating healthcare clinics in North America. The company was formerly known as Myconic Capital Corp. and changed its name to KetamineOne Capital Limited in June 2021. KetamineOne Capital Limited was founded in 2017 and is headquartered in Vancouver, Canada.
More Stocks
-
LBUY
-
B4P
-
000720
-
BIEBioera S.p.A.
BIE
-
MODGF
-
PDNLB
-
JDO
-
9544